πŸ‡ΊπŸ‡Έ FDA
Patent

US 11136405

BAFF-R antibodies and uses thereof

granted A61KA61K2039/505A61K40/11

Quick answer

US patent 11136405 (BAFF-R antibodies and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K40/11, A61K40/31, A61K40/4211